ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:BofA Securities 2026 Healthcare Conference – May 12-14, 2026Type: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results